Cargando…
Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
Objective: This study aims to evaluate the expression pattern of circulating microRNAs (miR)-486-5p, miR-497, miR-509-5p, and miR-605 in the serum of metabolic syndrome (MetS) Egyptian male patients. Methods: In this study, the circulating miR-486-5p, miR-497, miR509-5p, and miR-605 were amplified a...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511614/ https://www.ncbi.nlm.nih.gov/pubmed/31190928 http://dx.doi.org/10.2147/DMSO.S187422 |
_version_ | 1783417598092771328 |
---|---|
author | Bakr Zaki, Mohamed Abulsoud, Ahmed Ibrahim Elsisi, Ahmed Mohamed Doghish, Ahmed Soliman Mansour, Ossama Abd Elmotaal Amin, Ashraf Ismail Elrebehy, Mahmoud Ahmed Mohamed, Mohamed Yousef Goda, Mohamed Ahmed |
author_facet | Bakr Zaki, Mohamed Abulsoud, Ahmed Ibrahim Elsisi, Ahmed Mohamed Doghish, Ahmed Soliman Mansour, Ossama Abd Elmotaal Amin, Ashraf Ismail Elrebehy, Mahmoud Ahmed Mohamed, Mohamed Yousef Goda, Mohamed Ahmed |
author_sort | Bakr Zaki, Mohamed |
collection | PubMed |
description | Objective: This study aims to evaluate the expression pattern of circulating microRNAs (miR)-486-5p, miR-497, miR-509-5p, and miR-605 in the serum of metabolic syndrome (MetS) Egyptian male patients. Methods: In this study, the circulating miR-486-5p, miR-497, miR509-5p, and miR-605 were amplified and quantitatively detected by quantitative real-time polymerase chain reaction in sera of 55 MetS male patients in comparison to 20 male controls. The level of fasting plasma glucose and triacylglycerol (TAG) were measured using calorimetric assay. Blood pressure was measured using mercuric sphygmomanometer. Anthropometric measurements were done to each individual. Furthermore, MetS patients were defined according to the criteria proposed by the American Heart Association and divided into three groups according to MetS index. Results: The study was performed on three groups and a control group defined as follows: group 1: 15 MetS patients who fulfilled all diagnostic criteria of MetS; group 2: 20 MetS patients with normal blood pressure; group 3: 20 MetS patients with normal TAG levels.The levels of miRs are expressed as [median (IQR)]. miR-486-5-p and miR-497 expression were elevated in group 1 [31.9(49), p˂0.0001; 73.1(42.5), p˂0.0001], group 2 [36.4(15.7), p˂0.0001; 68.3(54.8), p˂0.0001], and group (3) [10.8(18.9), p=0.0014; 27.5(39.7), p=0.0012]. MiR-509-5p was elevated in groups 1 and 2 [501(468), p=0.0001], [309(436), p=0.0006], respectively, while normally expressed in group 3 [0.93(0.077), p=0.0001]. miR-605 was elevated in groups 1 and 3 [25.4(20.0), p=0.0018], [54.8(65.8), p˂0.0001], while normally expressed in group 2 [0.84(0.67), p˂0.0001]. Conclusion: miRs (486-5p, 497, 509-5p, and 605) serum levels were higher in MetS patients than in healthy control subjects; therefore, these serum miRs can serve as early biomarkers and can be used to follow-up the prognosis of MetS. |
format | Online Article Text |
id | pubmed-6511614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-65116142019-06-12 Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients Bakr Zaki, Mohamed Abulsoud, Ahmed Ibrahim Elsisi, Ahmed Mohamed Doghish, Ahmed Soliman Mansour, Ossama Abd Elmotaal Amin, Ashraf Ismail Elrebehy, Mahmoud Ahmed Mohamed, Mohamed Yousef Goda, Mohamed Ahmed Diabetes Metab Syndr Obes Original Research Objective: This study aims to evaluate the expression pattern of circulating microRNAs (miR)-486-5p, miR-497, miR-509-5p, and miR-605 in the serum of metabolic syndrome (MetS) Egyptian male patients. Methods: In this study, the circulating miR-486-5p, miR-497, miR509-5p, and miR-605 were amplified and quantitatively detected by quantitative real-time polymerase chain reaction in sera of 55 MetS male patients in comparison to 20 male controls. The level of fasting plasma glucose and triacylglycerol (TAG) were measured using calorimetric assay. Blood pressure was measured using mercuric sphygmomanometer. Anthropometric measurements were done to each individual. Furthermore, MetS patients were defined according to the criteria proposed by the American Heart Association and divided into three groups according to MetS index. Results: The study was performed on three groups and a control group defined as follows: group 1: 15 MetS patients who fulfilled all diagnostic criteria of MetS; group 2: 20 MetS patients with normal blood pressure; group 3: 20 MetS patients with normal TAG levels.The levels of miRs are expressed as [median (IQR)]. miR-486-5-p and miR-497 expression were elevated in group 1 [31.9(49), p˂0.0001; 73.1(42.5), p˂0.0001], group 2 [36.4(15.7), p˂0.0001; 68.3(54.8), p˂0.0001], and group (3) [10.8(18.9), p=0.0014; 27.5(39.7), p=0.0012]. MiR-509-5p was elevated in groups 1 and 2 [501(468), p=0.0001], [309(436), p=0.0006], respectively, while normally expressed in group 3 [0.93(0.077), p=0.0001]. miR-605 was elevated in groups 1 and 3 [25.4(20.0), p=0.0018], [54.8(65.8), p˂0.0001], while normally expressed in group 2 [0.84(0.67), p˂0.0001]. Conclusion: miRs (486-5p, 497, 509-5p, and 605) serum levels were higher in MetS patients than in healthy control subjects; therefore, these serum miRs can serve as early biomarkers and can be used to follow-up the prognosis of MetS. Dove 2019-05-06 /pmc/articles/PMC6511614/ /pubmed/31190928 http://dx.doi.org/10.2147/DMSO.S187422 Text en © 2019 Bakr Zaki et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Bakr Zaki, Mohamed Abulsoud, Ahmed Ibrahim Elsisi, Ahmed Mohamed Doghish, Ahmed Soliman Mansour, Ossama Abd Elmotaal Amin, Ashraf Ismail Elrebehy, Mahmoud Ahmed Mohamed, Mohamed Yousef Goda, Mohamed Ahmed Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients |
title | Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients |
title_full | Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients |
title_fullStr | Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients |
title_full_unstemmed | Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients |
title_short | Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients |
title_sort | potential role of circulating micrornas (486-5p, 497, 509-5p and 605) in metabolic syndrome egyptian male patients |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511614/ https://www.ncbi.nlm.nih.gov/pubmed/31190928 http://dx.doi.org/10.2147/DMSO.S187422 |
work_keys_str_mv | AT bakrzakimohamed potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT abulsoudahmedibrahim potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT elsisiahmedmohamed potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT doghishahmedsoliman potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT mansourossamaabdelmotaal potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT aminashrafismail potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT elrebehymahmoudahmed potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT mohamedmohamedyousef potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients AT godamohamedahmed potentialroleofcirculatingmicrornas4865p4975095pand605inmetabolicsyndromeegyptianmalepatients |